NNVC Stock Ownership Breakdown

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own NNVC shares is 34, representing 9.42% of the company's common stock.

TD WATERHOUSE CANADA INC., in the last quarter, reduced its stake in NNVC by -100% restricting it's holding to 0 shares of worth nearly -. BLACKROCK INC. also lessened -0.34% of the NNVC shares from its portfolio, reducing its holding to 158.75 thousand shares of worth $184.15K. UBS GROUP AG also shunned NNVC shares holding by -55.58% last quarter which brought its holding to 422 shares worth $490.00.

As per its latest 13F filing, JPMORGAN CHASE & CO increased its stake in NNVC by 14,314.29% in the last quarter. The institutional holder raised its holding to 3.03 thousand shares having worth more than $3.51K. TOWER RESEARCH CAPITAL LLC (TRC) also added 100% more shares of NNVC to its portfolio, raising its holding to 607 shares of worth $704.00. RENAISSANCE TECHNOLOGIES LLC also increased its NNVC shares holding by 7.64% which brought its holding to 84.5 thousand shares worth $98.00K.

The insider with the most stakes in NNVC is Theracour Pharma, Inc. , 10 percent owner at the company. Additionally, NNVC stock is highly held by Chief Executive Officer Seymour Eugene and President Diwan Anil among others.

Company executives, directors, and other insiders own 3.95% percent of NanoViricides, Inc.'s stock. Within the last six months, there have been 0 transaction(s) in which NNVC insiders have sold stock, totaling 0 shares. Insiders that have sold shares include DIWAN ANIL and THERACOUR PHARMA, INC..

There have been 0 transaction(s) during the past 6-months in which NanoViricides, Inc. insiders have bought stock, totalling 0 shares

Around 0 NanoViricides, Inc. shares are held by insiders, which represents about 3.95% of NNVC stock.

NNVC 10 percent owner, Theracour Pharma, Inc. holds the largest portfolio of the company's shares. NNVC shares owned by Theracour total nearly 33.32 million.

TD WATERHOUSE CANADA INC. is the largest institutional owner in NNVC which holds 0 shares worth - or 0% of the total NNVC shares outstanding followed by COMPAGNIE LOMBARD ODIER SCMA with ownership of 150 thousand shares representing 1.28% of the NNVC ownership. BLACKROCK INC. is the third largest stakeholder with 158.75 thousand shares or 1.35% of the ownership worth more than $184.15K.

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the NNVC is concerned, it is a stock which is optionable.

Number of NNVC shares short is 339.33K. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

As of today, 14.35M shares of NNVC are outstanding.

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, NNVC has 13.97M shares in float.

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for NNVC is 1.92.